ACE2 and viral load: Moreover, bepridil has demonstrated potential efficacy in combating viral diseases, such as its considerable anti-SARS-CoV-2 activity, exhibiting dose-dependent effectiveness in A459/ACE2 and Vero E6 cells [25].